Approximately 150,000 lung resections are performed in the United States every year. Intraoperative air leaks are a primary complication of lung surgery which can lead to other complications such as infections, pneumonia and extended hospitalization. Introducing Progel® Pleural Air Leak Sealant, the only commercially available, FDA approved Pleural Air Leak Sealant in the U.S. Following a multi-center clinical study in the U.S., it was shown that Progel PALS led to a statistically significant reduction in both intraoperative air leaks and hospital stay of nearly two days. Our Proprietary Hydrogel Technology Platform enables Neomend to develop advanced Wound Care products for a variety of applications, including wound sealing, prevention of post-surgical adhesions, and site specific, sustained drug delivery.
Location: United States, California, Irvine
Member count: 51-200
Total raised: $20M
Investors 1
| Date | Name | Website |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 02.08.2011 | Series D | $20M | - | - |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 27.01.2010 | Neomen... | Irvine-based Neomend, a develo... | - | - | socaltech.... |
| 27.01.2010 | Neomend Cl... | Neomend, Inc., an Irvine, CA-b... | USA ventu... | - | finsmes.co... |
| 21.05.2009 | NeoMen... | Irvine-based NeoMend, which is... | - | - | socaltech.... |